CD4 and neoplasm: The transcriptional analysis revealed a significantly higher frequency of circulating IFN-induced central memory CD4 T cells in responders (Fig. S2 D), further emphasizing the potential role of CD4 T cells not only in the tumor but also in the circulating T cell compartment in predicting nivolumab and ipilimumab response.